Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Saeui

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Plos One|May 31, 2018
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypesChristopher T Saeui, Alison V Nairn, Melina Galizzi, et al.
Clinical and Translational Science|October 16, 2020
Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation EngineeringPaul R Stabach, Kristin Zimmerman, Aaron Adame, et al.
Biotechnology Journal|September 18, 2018
Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and ProductionQiong Wang, Cheng-Yu Chung, Weiming Yang, et al.
Plos One|July 14, 2017
Determination of absolute expression profiles using multiplexed miRNA analysisYunke Song, Duncan Kilburn, Jee Hoon Song, et al.
The Journal of Biological Chemistry|February 6, 2026
Profiling the Pancreatic Cancer Secretome with Metabolic GlycoengineeringKris Dammen-Brower, Stanley Zhu, Christian Agatemor, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2009
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonistsGuo-Hua Chu, Christopher T Saeui, Karin Worm, et al.
Frontiers in Chemistry|March 3, 2020
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer ProgressionChristopher T Saeui, Kyung-Cho Cho, Vrinda Dharmarha, et al.
ACS Chemical Biology|January 10, 2023
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic PathwayChristopher T Saeui, Sagar R Shah, Beatriz I Fernandez-Gil, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonistsKarin Worm, Damian G Weaver, Rosalyn C Green, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos One|May 31, 2018
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypesChristopher T Saeui, Alison V Nairn, Melina Galizzi, et al.
Clinical and Translational Science|October 16, 2020
Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation EngineeringPaul R Stabach, Kristin Zimmerman, Aaron Adame, et al.
Biotechnology Journal|September 18, 2018
Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and ProductionQiong Wang, Cheng-Yu Chung, Weiming Yang, et al.
Plos One|July 14, 2017
Determination of absolute expression profiles using multiplexed miRNA analysisYunke Song, Duncan Kilburn, Jee Hoon Song, et al.
The Journal of Biological Chemistry|February 6, 2026
Profiling the Pancreatic Cancer Secretome with Metabolic GlycoengineeringKris Dammen-Brower, Stanley Zhu, Christian Agatemor, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Bioorganic & Medicinal Chemistry Letters|September 9, 2009
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonistsGuo-Hua Chu, Christopher T Saeui, Karin Worm, et al.
Frontiers in Chemistry|March 3, 2020
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer ProgressionChristopher T Saeui, Kyung-Cho Cho, Vrinda Dharmarha, et al.
ACS Chemical Biology|January 10, 2023
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic PathwayChristopher T Saeui, Sagar R Shah, Beatriz I Fernandez-Gil, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonistsKarin Worm, Damian G Weaver, Rosalyn C Green, et al.
Pageof 3